Related references
Note: Only part of the references are listed.An alpha(2C)-Adrenergic Receptor Polymorphism Alters the Norepinephrine-Lowering Effects and Therapeutic Response of the beta-Blocker Bucindolol in Chronic Heart Failure
Michael R. Bristow et al.
CIRCULATION-HEART FAILURE (2010)
HK-2 Human Renal Proximal Tubule Cells as a Model for G Protein-Coupled Receptor Kinase Type 4-Mediated Dopamine 1 Receptor Uncoupling
John J. Gildea et al.
HYPERTENSION (2010)
Common ADRB2 Haplotypes Derived from 26 Polymorphic Sites Direct β2-Adrenergic Receptor Expression and Regulation Phenotypes
Alfredo Panebra et al.
PLOS ONE (2010)
Common genetic variation of β1-and β2-adrenergic receptor and response to four classes of antihypertensive treatment
Timo Suonsyrja et al.
PHARMACOGENETICS AND GENOMICS (2010)
Haplotypes of the adrenergic system predict the blood pressure response to β-blockers in women with essential hypertension
Fabiana Filigheddu et al.
PHARMACOGENOMICS (2010)
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Mariell Jessup et al.
CIRCULATION (2009)
Clinical and Genetic Modifiers of Long-Term Survival in Heart Failure
Sharon Cresci et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Impact of β1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy
Andreia Biolo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
beta 1- and beta 2-adrenergic receptor gene beta-blocker use and risk of myocardial infarction and stroke
Rozenn N. Lemaitre et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Multiple interactions between the alpha2C- and beta1-adrenergic receptors influence heart failure survival
Sharon L. R. Kardia et al.
BMC MEDICAL GENETICS (2008)
β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
M. A. Pacanowski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol
Amy J. Sehnert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure
Stephen B. Liggett et al.
NATURE MEDICINE (2008)
Arg389Gly-β1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol
Lu Chen et al.
PHARMACOGENETICS AND GENOMICS (2007)
Pharmacogenetics of β-blockers
Jaekyu Shin et al.
PHARMACOTHERAPY (2007)
Synergistic polymorphisms of β1 and α2c-adrenergic receptors and the influence on left ventricular ejection fraction response to β-blocker therapy in heart failure
Maximilian T. Lobmeyer et al.
PHARMACOGENETICS AND GENOMICS (2007)
Relation of β2-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure
Jaekyu Shin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure
Stephen B. Liggett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
β1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension
Jie Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
GRKs and β-arrestins:: roles in receptor silencing, trafficking and signaling
Eric Reiter et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes
BP Head et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ser49Gly of β1-adrenergic receptor is associated with effective β-blocker dose in dilated cardiomyopathy
Y Magnusson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure
P de Groote et al.
PHARMACOGENETICS AND GENOMICS (2005)
β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure
JM Perez et al.
NATURE MEDICINE (2003)
β-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure
DM Kaye et al.
PHARMACOGENETICS (2003)
β1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
JA Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Hierarchy of polymorphic variation and desensitization permutations relative to β1- and β2-adrenergic receptor signaling
DA Rathz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The myocardium-protective Gly-49 variant of the β1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation
MC Levin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
G protein-coupled receptor kinase 4 gene variants in human essential hypertension
RA Felder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Amino acid 49 polymorphisms of the human β1-adrenergic receptor affect agonist-promoted trafficking
DA Rathz et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart
OE Brodde et al.
BASIC RESEARCH IN CARDIOLOGY (2001)
Dual modulation of cell survival and cell death by β2-adrenergic signaling in adult mouse cardiac myocytes
WZ Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
α2A/α2C-adrenergic receptor third loop chimera show that agonist interaction with receptor subtype backbone establishes G protein-coupled receptor kinase phosphorylation
EA Jewell-Motz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A four amino acid deletion polymorphism in the third intracellular loop of the human α2C-adrenergic receptor confers impaired coupling to multiple effectors
KM Small et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
